Table 3 The sequences of the oligonucleotide primers used in the study and the expected amplicon size

From: Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice

Target gene

Primer sequence (5′-3′)

Amplicon size (bp)

Ta °C

Binding site

RE site

BCAM1474

LY001: GGAGTgaattcATGTTCCGTCAAGCCTTGCTCGTCA

LY002: CGTCActcgagG ATCGACGGTGCGGCGCTCAATAC

1671

65

1638537–1640207

EcoRI

XhoI

BCAM2678

KT001: GCA AgaattcATGGCGGCGATGGTGGCGGGTA KT002: AATTCCCCActcgagACGCCCGATACCGAGCCT

1644

62

3024228–3025871

EcoRI

XhoI

BCAM0384

BD001: CGGTGaagcttATGAAAGCCGTTGCACTGATTGC

BD002: ACGCGCCctcgagATTCTGCGTGAGCGGATTTA

1005

60.2

434497–435501

HindIII

XhoI

pET22b -LY

LY003: CGAAGTAGCCCATCACCTGG

LY004: TATGAAATACCTGCTGCCGACC

607

52

1327–1933

-

pET22b -KT

KT003: TCTTCACGTAGTTGTGCGGG

KT004: TATGAAATACCTGCTGCCGACC

637

54

1270–1906

-

pET22b -BD

BD003: TCGTCGTGTACGTGTAGGTG

DB004: TATGAAATACCTGCTGCCGACC

629

52

658–1286

-